<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">CardioSomatics</journal-id><journal-title-group><journal-title xml:lang="en">CardioSomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>CardioСоматика</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2221-7185</issn><issn publication-format="electronic">2658-5707</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">44951</article-id><article-id pub-id-type="doi">10.26442/CS44951</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">A real way of reducing coronary heart disease mortality in Russia</article-title><trans-title-group xml:lang="ru"><trans-title>Реальный путь снижения в России смертности от ишемической болезни сердца</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Aronov</surname><given-names>D. M</given-names></name><name xml:lang="ru"><surname>Аронов</surname><given-names>Давид Меерович</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, проф., руководитель отдела ФГУ ГНИЦ профилактической медицины МЗ РФ</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bubnova</surname><given-names>M. G</given-names></name><name xml:lang="ru"><surname>Бубнова</surname><given-names>Марина Геннадьевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, проф.</p></bio><email>mbubnova@gnicPM.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">State Research Center of Preventive Medicine, Ministry of Health and Social Development of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГУ ГНИЦ профилактической медицины МЗ и СР РФ, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2010-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2010</year></pub-date><volume>1</volume><issue>1</issue><issue-title xml:lang="en">NO1 (2010)</issue-title><issue-title xml:lang="ru">ТОМ 1, №1 (2010)</issue-title><fpage>11</fpage><lpage>17</lpage><history><date date-type="received" iso-8601-date="2020-09-24"><day>24</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2010, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2010, ООО "Эко-Вектор"</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://cardiosomatics.ru/2221-7185/article/view/44951">https://cardiosomatics.ru/2221-7185/article/view/44951</self-uri><abstract xml:lang="en"><p>The paper analyzes reasons for high cardiovascular mortality in Russia and states that therapeutic work done by primary practitioners is ineffective. It gives the statistical data of the European Union, the USA, and some other countries where overmortality from cardiovascular diseases has been overcome by the governmental cardiovascular prevention and rehabilitation system. It is concluded that the experience of these countries can be applied to reduce cardiovascular overmortality in Russia</p></abstract><trans-abstract xml:lang="ru"><p>В статье дается анализ причин высокой смертности в России от сердечно-сосудистых заболеваний (ССЗ) и указывается, что лечебная работа, проводимая врачами первичного звена, малоэффективна. Приводятся статистические данные стран Европейского союза, США и некоторых других, где благодаря государственной системе профилактики и кардиальной реабилитации сверхсмертность от ССЗ была преодолена. Делается заключение о применимости опыта этих стран в снижении сверхсмертности от ССЗ в России.</p></trans-abstract><kwd-group xml:lang="en"><kwd>coronary heart disease</kwd><kwd>secondary prevention</kwd><kwd>cardiac rehabilitation</kwd><kwd>total mortality</kwd><kwd>statins</kwd><kwd>aspirin</kwd><kwd>beta-blockers</kwd><kwd>angiotensin-converting enzyme inhibitors</kwd><kwd>angiotensin receptor blockers</kwd><kwd>physical exercises</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ишемическая болезнь сердца</kwd><kwd>вторичная профилактика</kwd><kwd>кардиореабилитация</kwd><kwd>общая смертность</kwd><kwd>статины</kwd><kwd>аспирин</kwd><kwd>b-блокаторы</kwd><kwd>ингибиторы ангиотензинпревращающего фермента</kwd><kwd>блокаторы рецепторов ангиотензина</kwd><kwd>физические тренировки</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Аронов Д.М. и др. Результаты санаторной реабилитации больных инфарктом миокарда. Тер. арх. 1983; 1: 33–8.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Оганов Р.Г., Масленникова Г.Я. Смертность от сердечно - сосудистых и других хронических неинфекционных заболеваний среди трудоспособного населения в России. Кардиоваскул. тер. и вторичная профилак. 2003; 1 (3): 5–7.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Оганов Р.Г. и др. Особенности диагностики и терапии стабильной стенокардии в Российской Федерации (Международное исследование ATP – Angina Treatment Pottern). Кардиология. 2003; 5: 9–15.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Шхвацабая И.К., Аронов Д.М., Зайцев В.П. Реабилитация больных ишемической болезнью сердца. М.: Медицина, 1978.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Antithrombotic Trialists’ Collaboration, «Collaborative meta - analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients». BMJ 2002; 324 (7329): 71–86.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Berger J.S., Roncaglioni M.C., Avanzini F et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex - specific meta - analysis of randomized controlled trials. JAMA 2006; 295 (3): 306–13.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>de Gaetano G. Collaborative Group of the Primary Prevention Project. Low - dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 2001; 357 (9250): 89–95.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Pasquali S.K. et al. Am J Cardiol 2001; 88: 1415–6.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ridker P.M., Cook N.R., Lee I.M., Gordon D et al. A randomized trial of low - dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352 (13): 1293–304.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Taylor R.S. et al. Exercise - based rehabilitation for patients with coronary heart disease: review and metaanalysis of randomized controlled trials. Am J Med 2004; 116: 10.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>WHO Expert Committee. Rehabilitation after cardiovascular diseases, with special emphasis on developing countries. Geneva, 1993.</mixed-citation></ref></ref-list></back></article>
